"As the oldest and largest private teaching and specialty health care facility in Greater Cincinnati, TriHealth’s Good Samaritan Hospital is among the best hospitals in the region, providing a range of quality services to patients in Ohio, Indiana and Kentucky."

During the past decade, TriHealth conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 5 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "TriHealth" #1 sponsor was "TriHealth Inc." with 10 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Tempus Labs" with 2 trials sponsored, "Aadi Bioscience, Inc." with 1 trials sponsored and "Angion Biomedica Corp" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "TriHealth" #1 collaborator was "TriHealth Inc." with 2 trials as a collaborator, "AXIOM Real Time Metrics" with 1 trials as a collaborator, "Arrowhead Regional Medical Center" with 1 trials as a collaborator, "Aurora Health Care" with 1 trials as a collaborator and "Baylor College of Medicine" with 1 trials as a collaborator. Other collaborators include 67 different institutions and companies that were collaborators in the rest 77 trials.

According to Clinical.Site data, the most researched conditions in "TriHealth" are "Atrial Fibrillation" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Chronic Idiopathic Constipation" (2 trials), "Endometrial Cancer" (2 trials) and "Metastatic Cancer" (2 trials). Many other conditions were trialed in "TriHealth" in a lesser frequency.

Most popular intervention types in "TriHealth" are "Drug" (13 trials), "Device" (4 trials), "Behavioral" (3 trials), "Other" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Amivantamab" (2 trials), "Carboplatin" (2 trials), "Pemetrexed" (2 trials) and "ANG-3777" (1 trials). Other intervention names were less common.

The vast majority of trials in "TriHealth" are 16 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "TriHealth". undefined are not yet recruiting, 8 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in TriHealth, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in TriHealth, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".